Grants per year
Search results
-
Active
Prot #SC9-GBM-03: A Randomized, Open-Label, Multicentric, Two-Arm Pivotal Trial of SonoCloud-9 Combined with Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned Resection for First Recurrence Gliob
Lukas, R. V. (PD/PI)
Stiris Research Inc., CarThera SAS
8/27/24 → 8/27/27
Project: Research project
-
Project 2
Avery, R. J. (Co-Investigator), Avery, R. J. (Co-Investigator), Balyasnikova, I. V. (Co-Investigator), Balyasnikova, I. V. (Co-Investigator), Heimberger, A. B. (Co-Investigator), Heimberger, A. B. (Co-Investigator), Lukas, R. V. (Co-Investigator), Lukas, R. V. (Co-Investigator), Procissi, D. (Co-Investigator), Procissi, D. (Co-Investigator), Sonabend Worthalter, A. M. (Co-Investigator) & Sonabend Worthalter, A. M. (Co-Investigator)
8/1/23 → 7/31/28
Project: Research project
-
Prot #CYNK-001-GBM-002: A Phase I/IIa Open Label, Multicenter, Non- Randomized, Trial to Assess the Safety and Efficacy of CYNK-001 in Combination With Recombinant Human Interleukin-2 in Adults With Recurrent Resection Eligible IDH1 Wild Type Glioblastoma
Lukas, R. V. (PD/PI)
CTI Clinical Trial and Consulting Services, Celularity Inc
9/7/22 → 9/7/25
Project: Research project
-
Combination of Checkpoint inhibition and IDO1 together with Standard radiotherapy or chemoradiotherapy in newly diagnosed glioblastoma
Lukas, R. V. (PD/PI) & Lukas, R. V. (PD/PI)
7/1/21 → 7/1/25
Project: Research project